PDB111 EMPAGLIFLOZIN INDUCED PANCREATITIS: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.993
https://www.valueinhealthjournal.com/article/S1098-3015(19)33371-6/fulltext
Title :
PDB111 EMPAGLIFLOZIN INDUCED PANCREATITIS: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33371-6&doi=10.1016/j.jval.2019.09.993
First page :
Section Title :
Open access? :
No
Section Order :
10876